SCHEMBL18274755

SCHEMBL18274755

O=C(NSc1ccc(NCC2CCOCC2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCN(Cc3ccccc3N3CC4CCC(CC4)C3)CC2)cc1Oc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 10/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1958030 0.90 BCL2 (0.60) BCL2
SCHEMBL19410569 0.84 BCL2 (0.57) BCL2
SCHEMBL1956098 0.80 BCL2 (0.74) BCL2
SCHEMBL1959331 0.80 BCL2 (0.65) BCL2
SCHEMBL1958987 0.77 BCL2 (0.79) BCL2
SCHEMBL19419688 0.76 BCL2 (0.46) BCL2
SCHEMBL17419436 0.72 BCL2 (0.63) BCL2
SCHEMBL1958982 0.72 BCL2 (0.76) BCL2
SCHEMBL1958186 0.72 BCL2 (0.75) BCL2
SCHEMBL19425011 0.72 BCL2 (0.61) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3101019-A1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES AbbVie Inc. (US) 2016-12-07 — — EP disclosed
Send feedback